drugset / Trial / NCT00090142

Montelukast in Exercise-Induced Bronchospasm - 2004 (0476-275)

NCT00090142

Phase 3 Completed 62 enrolled Organon and Co
RandomizedCrossoverDouble-blindPrevention

Summary

The purpose of this study is to determine the effect of an approved medication being studied in support of a new approach in the prevention of exercise-induced asthma (a worsening of asthma caused by exercise, also known as exercise-induced bronchospasm), in patients who have a history of worsening asthma after exercise.

Timeline

Start
2004-05
Primary completion
2004-10
Completion
2004-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Montelukast Other / unclassified 10 mg Oral